APPOINTMENT OF PARESH BALDANIYA AS HEAD OF QUALITY & REGULATORY AFFAIRS
Paresh has a pharmacy background and a stellar track record
BIOCITY INVESTS IN MAXWELLIA
Life science incubator and business collective BioCity has announced an investment in Alderley Park-based Maxwellia
APPOINTMENT OF JACK GRIMSHAW AS FINANCE DIRECTOR
Jack brings to Maxwellia more than 10 years of finance experience across a range of industries
TOP MOVER AND SHAKER IN BIOBUSINESS 2019
Our CEO and founder, Anna Maxwell has been listed in the top 50 movers and shakers of 2019 by BioBusiness
BIOCITY INVESTS IN MAXWELLIA
Life science incubator and business collective BioCity has announced an investment in Alderley Park-based Maxwellia
POM TO P SWITCHES: WHAT MADE MALOFF PROTECT AND ELLAONE A SUCCESS?
C+D deputy editor Grace Lewis spoke to Anna Maxwell, CEO of Maxwellia, about what makes a successful POM to P change
MAXWELLIA MEETS THE HEALTH SECRETARY
Maxwellia had the opportunity to put the switch agenda on the radar of Matt Hancock, Secretary of State for Health and Social Care
THE POWER OF ALIGNING YOUR BUSINESS TO A GLOBAL GOAL
Maxwellia is mentioned in Forbes for aligning to Global Goal 3 Good Health
MAXWELLIA EXPANDS TEAM OF SWITCH EXPERTS AS IT BUILDS THE PRODUCT PIPELINE
Appointments will expedite conversion of prescription medicines to over the counter
UK IS FERTILE GROUND FOR SWITCHING
With the recent switch of Pfizer’s Viagra, the UK has shown itself to be an open and progressive market for prescription-to-OTC reclassification.
MAXWELLIA ANNOUNCES FUNDING TO ACCELERATE ITS MISSION FOR SELF CARE
Investment will expedite conversion of prescription medicines to over the counter
